Risk of multiple primary malignancies following treatment of Hodgkin lymphoma

A.M. van Eggermond, M. Schaapveld, P.J. Lugtenburg, A.D.G. Krol, J.P. de Boer, J.M. Zijlstra, J.M.M. Raemaekers, L.C.M. Kremer, J.M. Roesink, M.W.J. Louwman, B.M.P. Aleman, F.E. van Leeuwen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)319-327
JournalBlood
Volume124
Issue number3
DOIs
Publication statusPublished - 2014

Cite this

van Eggermond, A. M., Schaapveld, M., Lugtenburg, P. J., Krol, A. D. G., de Boer, J. P., Zijlstra, J. M., ... van Leeuwen, F. E. (2014). Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood, 124(3), 319-327. https://doi.org/10.1182/blood-2013-10-532184